Photothermal agents based on small organic fluorophores with intramolecular motion
Source abstract
Abstract
Photothermal therapy (PTT) has attracted great attention due to its noninvasive and low side effects. Photothermal agents (PTAs) which could convert absorbing light into heat play a critical role in PTT. For conventional small organic PTAs, the photothermal conversion ability is mainly achieved by intermolecular noncovalent interactions such as π-π interactions. However, in terms of organic fluorophores with rotator or vibrator segments, the balance between fluorescence emission and heat generation is mainly regulated by intramolecular motions which could be mediated by molecular engineering. Following this designing principle, various fluorophores with intramolecular motions for effective PTT have been reported. In this review, we highlight the recent progress of PTAs based on small organic fluorophores with intramolecular motions for enhanced PTT. Designing tactics of these fluorophores to afford long-wavelength absorption, high photothermal conversion ability, and effective accumulation capability are emphasized. Finally, one-for-all phototheranostics achieved by mediating intramolecular motions of these fluorophores are highlighted. We hope this review could pave a new avenue to developing fluorophores with intramolecular motion as PTAs to advance their clinical transition. STATEMENT OF SIGNIFICANCE: Recent progress of photothermal agents (PTAs) based on small organic fluorophores with intramolecular motion is summarized in this review. Molecular engineering of these small organic fluorophores to afford long-wavelength absorption, high photothermal conversion ability, and effective accumulation at tumor sites for enhanced photothermal therapy (PTT) is highlighted. Strategies to tune the intramolecular motions of these fluorophores to achieve multimodal phototherapy are emphasized as well.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Near infrared photothermal conversion materials: mechanism, preparation, and photothermal cancer therapy applications10.1039/D1TB01310F ↗
2. Recent progress on NIR-II photothermal therapy
3. Challenges and opportunities in cancer drug resistance10.1021/acs.chemrev.0c00383 ↗
4. A view on drug resistance in cancer10.1038/s41586-019-1730-1 ↗
5. Strategies to improve the photothermal capacity of gold-based nanomedicines10.1016/j.actbio.2020.09.008 ↗
6. Noble metal nanomaterials for NIR-triggered photothermal therapy in cancer10.1002/adhm.202001806 ↗
7. Two-dimensional nanomaterials for photothermal therapy10.1002/anie.201911477 ↗
8. Photoacoustic imaging and photothermal therapy of semiconducting polymer nanoparticles: signal amplification and second near-infrared construction10.1002/smll.202004723 ↗
9. Recent development in near-infrared photothermal therapy based on semiconducting polymer dots10.1021/acsapm.0c00629 ↗
10. Near-infrared small molecular fluorescent dyes for photothermal therapy10.1016/j.cclet.2019.02.003 ↗
11. Anti-photobleaching cyanine-based nanoparticles with simultaneous PET and ACQ effects for improved tumor photothermal therapy10.1016/j.cej.2021.134355 ↗
12. Phthalocyanines as contrast agents for photothermal therapy10.1016/j.ccr.2020.213548 ↗
13. Increasing photothermal efficacy by simultaneous intra- and intermolecular fluorescence quenching10.1002/adfm.201908073 ↗
14. Precise molecular design for high-performance luminogens with aggregation-induced emission10.1002/adma.201903530 ↗
15. Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations10.1002/adma.201900927 ↗
16. Inorganic nanomaterials with rapid clearance for biomedical applications10.1039/D0CS00461H ↗
17. Photosensitized singlet oxygen and its applications10.1016/S0010-8545(02)00034-6 ↗
18. Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization10.1016/S1572-1000(05)00007-4 ↗
19. Design of superior phototheranostic agents guided by Jablonski diagrams10.1039/D0CS00671H ↗
20. Aggregation-induced emission: together we shine, united we soar!10.1021/acs.chemrev.5b00263 ↗
21. Supramolecular photothermal nanomaterials as an emerging paradigm toward precision cancer therapy10.1002/adfm.201806877 ↗
22. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
23. Chlorosome-inspired synthesis of templated metallochlorin-lipid nanoassemblies for biomedical applications10.1021/acsnano.5b07151 ↗
24. Controlling spatial heat and light distribution by using photothermal enhancing auto-regulated liposomes (PEARLs)10.1002/anie.201605241 ↗
25. J-aggregates of cyanine dye for NIR-II in vivo dynamic vascular imaging beyond 1500 nm10.1021/jacs.9b10043 ↗
26. H-dimeric nanospheres of amphipathic squaraine dye with an 81.2% photothermal conversion efficiency for photothermal therapy
27. Highly efficient photothermal nanoagent achieved by harvesting energy via excited-state intramolecular motion within nanoparticles10.1038/s41467-019-08722-z ↗
28. Nanocrystallization: a unique approach to yield bright organic nanocrystals for biological applications10.1002/adma.201604100 ↗
29. Nanoprobes with aggregation-induced emission for theranostics10.1039/D0QM00617C ↗
30. Evoking photothermy by capturing intramolecular bond stretching vibration-induced dark-state energy10.1021/acsnano.9b09625 ↗
31. Band gap tunable, donor−acceptor−donor charge-transfer heteroquinoid-based chromophores: near infrared photoluminescence and electroluminescence10.1021/cm801911n ↗
32. Constitutional isomerization enables bright NIR-II AIEgen for brain-inflammation imaging10.1002/adfm.201908125 ↗
33. Photoacoustic imaging and photothermal therapy of semiconducting polymer nanoparticles: signal amplification and second near-infrared construction10.1002/smll.202004723 ↗
34. Second near-infrared photothermal materials for combinational nanotheranostics10.1039/D0CS00664E ↗
35. Rational molecular design for achieving persistent and efficient pure organic room-temperature phosphorescence10.1016/j.chempr.2016.08.010 ↗
36. A borondifluoride-complex-based photothermal agent with an 80 % photothermal conversion efficiency for photothermal therapy in the NIR-II window10.1002/anie.202107836 ↗
37. Precise molecular engineering of small organic phototheranostic agents toward multimodal imaging-guided synergistic therapy10.1021/acsnano.1c00585 ↗
38. An all-round athlete on the track of phototheranostics: subtly regulating the balance between radiative and nonradiative decays for multimodal imaging-guided synergistic therapy10.1002/adma.202003210 ↗
39. Evaluation of structure-function relationships of aggregation-induced emission luminogens for simultaneous dual applications of specific discrimination and efficient photodynamic killing of gram-positive bacteria10.1021/jacs.9b07162 ↗
40. Zwitterionic AIEgens: rational molecular design for NIR-II fluorescence imaging-guided synergistic phototherapy10.1002/adfm.202007026 ↗
41. Molecular motion in aggregates: manipulating TICT for boosting photothermal theranostics10.1021/jacs.8b13889 ↗
42. Organic molecules with propeller structures for efficient photoacoustic imaging and photothermal ablation of cancer cells10.1039/C7QM00056A ↗
43. Xanthene-based NIR-II dyes for in vivo dynamic imaging of blood circulation10.1021/jacs.1c07711 ↗
44. Side-chain-extended conjugation: a strategy for improving the photocatalytic hydrogen production performance of a linear conjugated polymer10.1039/D0TA12425G ↗
45. Making the best use of excited-state energy: multimodality theranostic systems based on second near-infrared (NIR-II) aggregation-induced emission luminogens (AIEgens)10.1021/acsmaterialslett.0c00263 ↗
46. NIR light-driving barrier-free group rotation in nanoparticles with an 88.3% photothermal conversion efficiency for photothermal therapy10.1002/adma.201907855 ↗
47. Boosting non-radiative decay to do useful work: development of a multi-modality theranostic system from an AIEgen10.1002/anie.201900366 ↗
48. Highly stable organic small molecular nanoparticles as an advanced and biocompatible phototheranostic agent of tumor in living mice10.1021/acsnano.7b03062 ↗
49. One-for-all phototheranostic agent based on aggregation-induced emission characteristics for multimodal imaging-guided synergistic photodynamic/photothermal cancer therapy10.1021/acsami.1c02260 ↗
50. Molecular engineering of D–A–D conjugated small molecule nanoparticles for high performance NIR-II photothermal therapy10.1039/C9MH00660E ↗
51. Upregulating aggregation-induced-emission nanoparticles with blood-tumor-barrier permeability for precise photothermal eradication of brain tumors and induction of local immune responses10.1002/adma.202008802 ↗
52. NIR-II emissive multifunctional AIEgen with single laser-activated synergistic photodynamic/photothermal therapy of cancers and pathogens10.1016/j.biomaterials.2020.120315 ↗
53. NIR-absorbing dye based on BF2-bridged azafulvene dimer as a strong electron-accepting unit10.1021/acs.orglett.8b02056 ↗
54. Near-infrared (>1000 nm) light-harvesters: design, synthesis and applications10.1002/chem.202001126 ↗
55. Design, synthesis, and properties of benzobisthiadiazole-based donor–π–acceptor–π–donor type of low-band-gap chromophores and polymers10.1139/v09-157 ↗
56. Intriguing H-aggregates of heptamethine cyanine for imaging-guided photothermal cancer therapy10.1021/acsami.0c07608 ↗
57. Perylene-diimide-based nanoparticles as highly efficient photoacoustic agents for deep brain tumor imaging in living mice10.1002/adma.201402972 ↗
58. Intriguing H-aggregates of heptamethine cyanine for imaging-guided photothermal cancer therapy10.1021/acsami.0c07608 ↗
59. Fluorescence quenching nanoprobes dedicated to in vivo photoacoustic imaging and high-efficient tumor therapy in deep-seated tissue10.1002/smll.201403395 ↗
60. Intraparticle molecular orbital engineering of semiconducting polymer nanoparticles as amplified theranostics for in vivo photoacoustic imaging and photothermal therapy10.1021/acsnano.6b00168 ↗
61. Bodipy derivatives as triplet photosensitizers and the related intersystem crossing mechanisms10.3389/fchem.2019.00821 ↗
62. Boosting photothermal theranostics via TICT and molecular motions for photohyperthermia therapy of muscle-invasive bladder cancer
63. Albumin tailoring fluorescence and photothermal conversion effect of near-infrared-II fluorophore with aggregation-induced emission characteristics10.1038/s41467-019-10056-9 ↗
64. Twisted intramolecular charge transfer and aggregation-induced emission of BODIPY derivatives10.1021/jp902962h ↗
65. Aggregation-induced emission nanoprobes working in the NIR-II region: from material design to fluorescence imaging and phototherapy10.1002/adom.202100859 ↗
66. Aggregation-induced emission: the whole is more brilliant than the parts10.1002/adma.201401356 ↗
67. Molecular mechanism of aggregation-induced emission10.1002/agt2.91 ↗
68. Near-infrared absorbing aza-BODIPYs with 1,7-di-tert-butyl groups by low-barrier rotation for photothermal application10.1039/D1MA01052B ↗
69. The fast-growing field of photo-driven theranostics based on aggregation-induced emission10.1039/D1CS01138C ↗
70. A tumor-targeting near-infrared heptamethine cyanine photosensitizer with twisted molecular structure for enhanced imaging-guided cancer phototherapy10.1021/jacs.1c09155 ↗
71. Structural and theoretical insights into the AIE attributes of phosphindole oxide: the balance between rigidity and flexibility10.1002/chem.201405902 ↗
72. Tumor targeting strategies of smart fluorescent nanoparticles and their applications in cancer diagnosis and treatment10.1002/adma.201902409 ↗
73. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer10.1039/C8CS00618K ↗
74. Dual-targeted photothermal agents for enhanced cancer therapy10.1039/D0SC03173A ↗
75. Passive cancer targeting with a viral nanoparticle depends on the stage of tumorigenesis10.1039/D1NR01619A ↗
76. Single-molecular near-infrared-II theranostic systems: ultrastable aggregation-induced emission nanoparticles for long-term tracing and efficient photothermal therapy10.1021/acsnano.8b05937 ↗
77. Delivering nanomedicine to solid tumors10.1038/nrclinonc.2010.139 ↗
78. Simple D-A-D structural bisbithiophenyl diketopyrrolopyrrole as efficient bioimaging and photothermal agents10.1021/acs.bioconjchem.8b00333 ↗
79. Nanoscale metal-organic framework mediates radical therapy to enhance cancer immunotherapy10.1016/j.chempr.2019.05.013 ↗
80. PEGylation of lipophilic SN38 prodrug with DSPE-mPEG(2000) versus cremophor EL: comparative study for intravenous chemotherapy10.1080/10717544.2019.1587045 ↗
81. High-security nanocluster for switching photodynamic combining photothermal and acid-induced drug compliance therapy guided by multimodal active-targeting imaging10.1002/adfm.201803118 ↗
82. TICT-based near-infrared ratiometric organic fluorescent thermometer for intracellular temperature sensing10.1021/acsami.0c03714 ↗
83. Metal-organic framework derived multicomponent nanoagent as a reactive oxygen species amplifier for enhanced photodynamic therapy10.1021/acsnano.0c05499 ↗
84. A near infrared photothermal therapy hydrogel with high conversion efficiency for eliminating of breast cancer cells
85. Small organic molecule-based nanoparticles with red/near-infrared aggregation-induced emission for bioimaging and PDT/PTT synergistic therapy10.1039/D0QM00536C ↗
86. Fabrication of fluorescent nanoparticles based on AIE luminogens (AIE dots) and their applications in bioimaging10.1039/C6MH00060F ↗
87. Long-term fluorescent cellular tracing by the aggregates of AIE bioconjugates10.1021/ja312581r ↗
88. Fabrication of fluorescent silica nanoparticles hybridized with AIE luminogens and exploration of their applications as nanobiosensors in intracellular imaging10.1002/chem.200901823 ↗
89. An organic nanotherapeutic agent self-assembled from cyanine and Cu (II) for combined photothermal and chemodynamic therapy10.1002/adhm.202101008 ↗
90. Utilization of nonradiative excited-state dissipation for promoted phototheranostics based on an AIE-active type I ROS generator10.1021/acsami.1c19008 ↗
91. A polydopamine-coated platinum nanoplatform for tumor-targeted photothermal ablation and migration inhibition10.3389/fonc.2022.860718 ↗
92. Chlorin e6-biotin conjugates for tumor-targeting photodynamic therapy10.3390/molecules26237342 ↗
93. Achieving high-performance photothermal and photodynamic effects upon combining D-A structure and nonplanar conformation10.1002/smll.202000909 ↗
94. Conjugated polymer and triphenylamine derivative codoped nanoparticles for photothermal and photodynamic antimicrobial therapy10.1021/acsabm.0c00320 ↗
95. 9,10-phenanthrenequinone: a promising kernel to develop multifunctional antitumor systems for efficient Type I photodynamic and photothermal synergistic therapy10.1021/acsnano.1c07730 ↗
96. Light-driven transformable optical agent with adaptive functions for boosting cancer surgery outcomes10.1038/s41467-018-04222-8 ↗
97. Highly efficient organic light-emitting diodes from delayed fluorescence10.1038/nature11687 ↗
98. Triplet photosensitizers: from molecular design to applications10.1039/c3cs35531d ↗
99. Room-temperature phosphorescence from organic aggregates10.1038/s41578-020-0223-z ↗
100. Synchronously boosting type-I photodynamic and photothermal efficacies via molecular manipulation for pancreatic cancer theranostics in the NIR-II window10.1016/j.biomaterials.2022.121476 ↗